• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

胃肠道间质瘤的 microRNA 表达谱由 14q 缺失和解剖部位区分。

MicroRNA expression profile of gastrointestinal stromal tumors is distinguished by 14q loss and anatomic site.

机构信息

Department of Pathology, Yonsei University College of Medicine, Seoul, Korea.

出版信息

Int J Cancer. 2010 Apr 1;126(7):1640-50. doi: 10.1002/ijc.24897.

DOI:10.1002/ijc.24897
PMID:19795448
Abstract

MicroRNAs are known to regulate gene expression. Although unique microRNA expression profiles have been reported in several tumors, little is known about microRNA expression profiles in GISTs. To evaluate the relationship between microRNA expression and clinicopathologic findings of GISTs, we analyzed the microRNA expression profiles of GISTs. We used fresh frozen tissues from 20 GISTs and analyzed KIT and PDGFRA mutations and chromosomal loss status. MicroRNA expression was analyzed using a microRNA chip containing 470 microRNAs. Using unsupervised hierarchical clustering analysis, we found four distinct microRNA expression patterns in our 20 GISTs. Six GISTs that did not have 14q loss formed a separate cluster. In the 14 GISTs with 14q loss, 5 small bowel GISTs formed a separate cluster and the remaining 9 GISTs could be divided into two groups according to frequent chromosomal losses and tumor risk. We found 73 microRNAs that were significantly down-regulated in the GISTs with 14q loss; 38 of these microRNAs are encoded on 14q. We also found many microRNAs that were down-regulated in small bowel and high-risk group GISTs. Most of the microRNAs down-regulated in the high-risk group and small bowel GISTs are known to be involved in tumor progression, specifically by stimulating mitogen-activated protein kinase (MAPK) and the cell cycle. The microRNA expression patterns of GISTs are closely related to the status of 14q loss, anatomic site, and tumor risk. These findings suggest that microRNA expression patterns can differentiate several subsets of GISTs.

摘要

MicroRNAs 已知可以调节基因表达。虽然已经在几种肿瘤中报道了独特的 microRNA 表达谱,但对 GISTs 的 microRNA 表达谱知之甚少。为了评估 microRNA 表达与 GISTs 的临床病理发现之间的关系,我们分析了 GISTs 的 microRNA 表达谱。我们使用来自 20 个 GISTs 的新鲜冷冻组织,分析了 KIT 和 PDGFRA 突变以及染色体缺失状态。使用包含 470 个 microRNAs 的 microRNA 芯片分析 microRNA 表达。通过非监督层次聚类分析,我们在 20 个 GISTs 中发现了四种不同的 microRNA 表达模式。没有 14q 缺失的 6 个 GISTs形成了一个单独的簇。在 14q 缺失的 14 个 GISTs中,5 个小肠 GISTs形成了一个单独的簇,其余 9 个 GISTs可以根据频繁的染色体缺失和肿瘤风险分为两组。我们发现 73 个 microRNAs 在 14q 缺失的 GISTs 中显著下调;其中 38 个 microRNAs 编码在 14q 上。我们还发现许多 microRNAs在小肠和高风险组 GISTs 中下调。在高风险组和小肠 GISTs 中下调的大多数 microRNAs 已知参与肿瘤进展,特别是通过刺激丝裂原活化蛋白激酶(MAPK)和细胞周期。GISTs 的 microRNA 表达模式与 14q 缺失、解剖部位和肿瘤风险密切相关。这些发现表明 microRNA 表达模式可以区分 GISTs 的几个亚群。

相似文献

1
MicroRNA expression profile of gastrointestinal stromal tumors is distinguished by 14q loss and anatomic site.胃肠道间质瘤的 microRNA 表达谱由 14q 缺失和解剖部位区分。
Int J Cancer. 2010 Apr 1;126(7):1640-50. doi: 10.1002/ijc.24897.
2
Neurofibromatosis type 1-related gastrointestinal stromal tumors: a special reference to loss of heterozygosity at 14q and 22q.1型神经纤维瘤病相关的胃肠道间质瘤:特别提及14号染色体长臂和22号染色体长臂杂合性缺失
J Cancer Res Clin Oncol. 2009 Jun;135(6):791-8. doi: 10.1007/s00432-008-0514-z. Epub 2008 Nov 20.
3
Expression profiling of GIST: CD133 is associated with KIT exon 11 mutations, gastric location and poor prognosis.GIST 的表达谱分析:CD133 与 KIT 外显子 11 突变、胃来源和不良预后相关。
Int J Cancer. 2011 Sep 1;129(5):1149-61. doi: 10.1002/ijc.25755. Epub 2011 Jan 7.
4
Localization- and mutation-dependent microRNA (miRNA) expression signatures in gastrointestinal stromal tumours (GISTs), with a cluster of co-expressed miRNAs located at 14q32.31.定位和突变依赖性微小 RNA(miRNA)表达特征在胃肠道间质瘤(GISTs)中,有一群共表达的 miRNA 位于 14q32.31。
J Pathol. 2010 Jan;220(1):71-86. doi: 10.1002/path.2610.
5
Array CGH analysis in primary gastrointestinal stromal tumors: cytogenetic profile correlates with anatomic site and tumor aggressiveness, irrespective of mutational status.原发性胃肠道间质瘤的阵列比较基因组杂交分析:细胞遗传学特征与解剖部位及肿瘤侵袭性相关,与突变状态无关。
Genes Chromosomes Cancer. 2007 Mar;46(3):261-76. doi: 10.1002/gcc.20408.
6
MicroRNA-494 downregulates KIT and inhibits gastrointestinal stromal tumor cell proliferation.MicroRNA-494 下调 KIT 并抑制胃肠道间质瘤细胞增殖。
Clin Cancer Res. 2011 Dec 15;17(24):7584-94. doi: 10.1158/1078-0432.CCR-11-0166. Epub 2011 Oct 31.
7
Down-regulation of miR-221 and miR-222 correlates with pronounced Kit expression in gastrointestinal stromal tumors.miR-221 和 miR-222 的下调与胃肠道间质瘤中明显的 Kit 表达相关。
Int J Oncol. 2011 Feb;38(2):503-11. doi: 10.3892/ijo.2010.857. Epub 2010 Dec 3.
8
Correlation of KIT and platelet-derived growth factor receptor alpha mutations with gene activation and expression profiles in gastrointestinal stromal tumors.胃肠道间质瘤中KIT和血小板衍生生长因子受体α突变与基因激活及表达谱的相关性
Oncogene. 2005 Feb 3;24(6):1066-74. doi: 10.1038/sj.onc.1208358.
9
Gastrointestinal stromal tumors in children and young adults: a clinicopathologic, molecular, and genomic study of 15 cases and review of the literature.儿童和青年胃肠道间质瘤:15例临床病理、分子及基因组研究并文献复习
J Pediatr Hematol Oncol. 2005 Apr;27(4):179-87. doi: 10.1097/01.mph.0000157790.81329.47.
10
High expression of the RNA-binding protein RBPMS2 in gastrointestinal stromal tumors.RNA 结合蛋白 RBPMS2 在胃肠道间质瘤中的高表达。
Exp Mol Pathol. 2013 Apr;94(2):314-21. doi: 10.1016/j.yexmp.2012.12.004. Epub 2013 Jan 4.

引用本文的文献

1
Exploring nanotechnology solutions for improved outcomes in gastrointestinal stromal tumors.探索用于改善胃肠道间质瘤治疗效果的纳米技术解决方案。
Heliyon. 2024 Nov 22;10(23):e40596. doi: 10.1016/j.heliyon.2024.e40596. eCollection 2024 Dec 15.
2
MicroRNA expression signature in gastrointestinal stromal tumour & their molecular & histological features.胃肠道间质瘤的 microRNA 表达谱及其分子和组织学特征。
Indian J Med Res. 2024 Jul;160(1):118-127. doi: 10.25259/ijmr_2567_22.
3
KIT mutations and expression: current knowledge and new insights for overcoming IM resistance in GIST.
KIT 突变和表达:克服 GIST 中 IM 耐药的最新知识和新见解。
Cell Commun Signal. 2024 Feb 27;22(1):153. doi: 10.1186/s12964-023-01411-x.
4
Non-Coding RNAs, a Novel Paradigm for the Management of Gastrointestinal Stromal Tumors.非编码 RNA:胃肠道间质瘤治疗的新模式。
Int J Mol Sci. 2020 Sep 22;21(18):6975. doi: 10.3390/ijms21186975.
5
MiR-374b Promotes Proliferation and Inhibits Apoptosis of Human GIST Cells by Inhibiting PTEN through Activation of the PI3K/Akt Pathway.miR-374b 通过激活 PI3K/Akt 通路抑制 PTEN 促进人 GIST 细胞增殖并抑制其凋亡。
Mol Cells. 2018 Jun;41(6):532-544. doi: 10.14348/molcells.2018.2211. Epub 2018 Jun 14.
6
miR-148b-3p functions as a tumor suppressor in GISTs by directly targeting KIT.miR-148b-3p 通过直接靶向 KIT 在 GISTs 中发挥肿瘤抑制作用。
Cell Commun Signal. 2018 Apr 16;16(1):16. doi: 10.1186/s12964-018-0228-z.
7
Molecular characterization and pathogenesis of gastrointestinal stromal tumor.胃肠道间质瘤的分子特征与发病机制
Transl Gastroenterol Hepatol. 2018 Jan 9;3:2. doi: 10.21037/tgh.2018.01.02. eCollection 2018.
8
Small Molecules in Rare Tumors: Emerging Role of MicroRNAs in GIST.罕见肿瘤中的小分子:miRNAs 在 GIST 中的新作用。
Int J Mol Sci. 2018 Jan 30;19(2):397. doi: 10.3390/ijms19020397.
9
Survivin is a novel transcription regulator of KIT and is downregulated by miRNA-494 in gastrointestinal stromal tumors.Survivin 是 KIT 的一种新型转录调节因子,在胃肠道间质肿瘤中被 miRNA-494 下调。
Int J Cancer. 2018 May 15;142(10):2080-2093. doi: 10.1002/ijc.31235. Epub 2018 Jan 22.
10
MiRNA profiling of gastrointestinal stromal tumors by next-generation sequencing.通过下一代测序对胃肠道间质瘤进行微小RNA分析
Oncotarget. 2017 Jun 6;8(23):37225-37238. doi: 10.18632/oncotarget.16664.